Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis
Xiaolin He, Monica F. Tolosa, Tianzhou Zhang, Santosh Kumar Goru, Luisa Ulloa Severino, Paraish S. Misra, Caitríona M. McEvoy, Lauren Caldwell, Stephen G. Szeto, Feng Gao, Xiaolan Chen, Cassandra Atin, Victoria Ki, Noah Vukosa, Catherine Hu, Johnny Zhang, Christopher Yip, Adriana Krizova, Jeffrey L. Wrana, Darren A. Yuen
Xiaolin He, Monica F. Tolosa, Tianzhou Zhang, Santosh Kumar Goru, Luisa Ulloa Severino, Paraish S. Misra, Caitríona M. McEvoy, Lauren Caldwell, Stephen G. Szeto, Feng Gao, Xiaolan Chen, Cassandra Atin, Victoria Ki, Noah Vukosa, Catherine Hu, Johnny Zhang, Christopher Yip, Adriana Krizova, Jeffrey L. Wrana, Darren A. Yuen
View: Text | PDF
Research Article Nephrology Pulmonology

Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis

  • Text
  • PDF
Abstract

Fibrotic diseases account for nearly half of all deaths in the developed world. Despite its importance, the pathogenesis of fibrosis remains poorly understood. Recently, the two mechanosensitive transcription cofactors YAP and TAZ have emerged as important profibrotic regulators in multiple murine tissues. Despite this growing recognition, a number of important questions remain unanswered, including which cell types require YAP/TAZ activation for fibrosis to occur and the time course of this activation. Here, we present a detailed analysis of the role that myofibroblast YAP and TAZ play in organ fibrosis and the kinetics of their activation. Using analyses of cells, as well as multiple murine and human tissues, we demonstrated that myofibroblast YAP and TAZ were activated early after organ injury and that this activation was sustained. We further demonstrated the critical importance of myofibroblast YAP/TAZ in driving progressive scarring in the kidney, lung, and liver, using multiple transgenic models in which YAP and TAZ were either deleted or hyperactivated. Taken together, these data establish the importance of early injury-induced myofibroblast YAP and TAZ activation as a key event driving fibrosis in multiple organs. This information should help guide the development of new antifibrotic YAP/TAZ inhibition strategies.

Authors

Xiaolin He, Monica F. Tolosa, Tianzhou Zhang, Santosh Kumar Goru, Luisa Ulloa Severino, Paraish S. Misra, Caitríona M. McEvoy, Lauren Caldwell, Stephen G. Szeto, Feng Gao, Xiaolan Chen, Cassandra Atin, Victoria Ki, Noah Vukosa, Catherine Hu, Johnny Zhang, Christopher Yip, Adriana Krizova, Jeffrey L. Wrana, Darren A. Yuen

×

Figure 3

Myofibroblast YAP and TAZ are progressively activated during renal fibrogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Myofibroblast YAP and TAZ are progressively activated during renal fibro...
Male C57BL/6 mice underwent sham (n = 4) or left-sided unilateral ischemia/reperfusion injury (IRI, n = 8) surgery. IRI mice were euthanized at early (4 days, n = 4) or late (14 days, n = 4) time points after injury. Sham-operated mice were euthanized at 14 days after surgery. (A) Kidney sections were stained with picrosirius red to quantify fibrotic injury. Black scale bar: 100 μm. (B) To quantify myofibroblast YAP activation, kidneys were costained with antibodies directed against α-smooth muscle actin (α-SMA, green) and YAP (red) with nuclear DAPI counterstaining (blue). White scale bar: 10 μm. (C) Myofibroblast TAZ activation was similarly assessed after costaining for α-SMA (green), TAZ (red), and DAPI (blue). White arrows depict green α-SMA+ cells that have predominantly red YAP or TAZ nuclear staining. White scale bar: 10 μm. (D–G) The mRNA levels of the YAP/TAZ-inducible genes (D) Ccn2 and (E) Ccn1 and the fibrosis-associated genes (F) Col1a1 and (G) Col3a1 were examined using qPCR of cDNA prepared from whole kidney homogenates. Transcript levels were normalized to the housekeeper transcript Gapdh. One-way ANOVA with post hoc Tukey’s test was used for comparisons. Data shown as mean ± SEM. *P < 0.05. d4, 4 days after-IRI. d14, 14 days after IRI.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts